NJ Retina Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT02349516
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Leonard Feiner, MD, PhD | NJ Retina (Retina Associates of New Jersey)